| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | CHINOOK THERAPEUTICS, INC. | KDNY | Disposition | Common Stock | 447k | $0.00 | $0 | | 08/11/2023 |
| 08/11/2023 | CHINOOK THERAPEUTICS, INC. | KDNY | Disposition | Common Stock | 2.1M | $0.00 | $0 | See Footnote | 08/11/2023 |
| 08/11/2023 | CHINOOK THERAPEUTICS, INC. | KDNY | Disposition | Common Stock | 719.1k | $0.00 | $0 | See Footnote | 08/11/2023 |
| 08/11/2023 | CHINOOK THERAPEUTICS, INC. | KDNY | Disposition | Common Stock | 211k | $0.00 | $0 | See Footnote | 08/11/2023 |
| 08/11/2023 | CHINOOK THERAPEUTICS, INC. | KDNY | Disposition | Stock Option (Right to Buy) | 23.5k | $14.77 | $347.4k | | 08/11/2023 |
| 08/11/2023 | CHINOOK THERAPEUTICS, INC. | KDNY | Disposition | Stock Option (Right to Buy) | 5.9k | $16.81 | $100k | | 08/11/2023 |
| 08/11/2023 | CHINOOK THERAPEUTICS, INC. | KDNY | Disposition | Stock Option (Right to Buy) | 13.3k | $13.88 | $184.6k | | 08/11/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series B-1 Preferred Stock | 3.5M | $0.00 | $0 | By Versant Venture Capital V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series B-1 Preferred Stock | 268.7k | $0.00 | $0 | By Versant Venture Capital V (Canada) LP | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series B-1 Preferred Stock | 117.7k | $0.00 | $0 | By Versant Ophthalmic Affiliates Fund I, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series B-1 Preferred Stock | 106.2k | $0.00 | $0 | By Versant Affiliates Fund V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series B-2 Preferred Stock | 7.7M | $0.00 | $0 | By Versant Venture Capital V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series B-2 Preferred Stock | 582.2k | $0.00 | $0 | By Versant Venture Capital V (Canada) LP | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Common Stock | 2.5M | $0.00 | $0 | By Versant Venture Capital V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Common Stock | 192.5k | $0.00 | $0 | By Versant Venture Capital V (Canada) LP | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Common Stock | 84.3k | $0.00 | $0 | By Versant Ophthalmic Affiliates Fund I, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Common Stock | 76.1k | $0.00 | $0 | By Versant Affiliates Fund V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Common Stock | 275k | $0.00 | $0 | By Versant Vantage II, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Purchase | Common Stock | 197.5k | $12.00 | $2.4M | By Versant Venture Capital V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Purchase | Common Stock | 15k | $12.00 | $180.3k | By Versant Venture Capital V (Canada) LP | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Purchase | Common Stock | 6.6k | $12.00 | $78.9k | By Versant Ophthalmic Affiliates Fund I, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Purchase | Common Stock | 5.9k | $12.00 | $71.3k | By Versant Affiliates Fund V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series A Preferred Stock | 7.9M | $0.00 | $0 | By Versant Venture Capital V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series A Preferred Stock | 601.1k | $0.00 | $0 | By Versant Venture Capital V (Canada) LP | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series A Preferred Stock | 263.3k | $0.00 | $0 | By Versant Ophthalmic Affiliates Fund I, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series A Preferred Stock | 237.6k | $0.00 | $0 | By Versant Affiliates Fund V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series B-2 Preferred Stock | 255.1k | $0.00 | $0 | By Versant Ophthalmic Affiliates Fund I, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series B-2 Preferred Stock | 230.1k | $0.00 | $0 | By Versant Affiliates Fund V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series C Preferred Stock | 1.1M | $0.00 | $0 | By Versant Venture Capital V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series C Preferred Stock | 85.2k | $0.00 | $0 | By Versant Venture Capital V (Canada) LP | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series C Preferred Stock | 37.3k | $0.00 | $0 | By Versant Ophthalmic Affiliates Fund I, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series C Preferred Stock | 33.7k | $0.00 | $0 | By Versant Affiliates Fund V, L.P. | 07/25/2023 |
| 07/25/2023 | Turnstone Biologics Corp. | | Conversion | Series D Preferred Stock | 2.2M | $0.00 | $0 | By Versant Vantage II, L.P. | 07/25/2023 |
| 05/26/2023 | CHINOOK THERAPEUTICS, INC. | KDNY | Exercise | Restricted Stock Units | 3.3k | $0.00 | $0 | | 05/26/2023 |
| 12/29/2022 | Repare Therapeutics Inc. | RPTX | Other (disposition) | Common Shares | 287.2k | $0.00 | $0 | See Footnote | 12/29/2022 |
|